Cite
HARVARD Citation
Driessen, M. et al. (2018). Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective. Respiratory medicine. pp. 130-137. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Driessen, M. et al. (2018). Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective. Respiratory medicine. pp. 130-137. [Online].